EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of a heparin assay method using a fluorogenic synthetic peptide substrate for thrombin


Thrombosis Research 25(1-2): 115-124
Evaluation of a heparin assay method using a fluorogenic synthetic peptide substrate for thrombin
A heparin assay method based on thrombin cleavage of a fluorogenic synthetic peptide was evaluated in normal subjects, in patients with chronic renal disease on hemodialysis and in patients with other disorders. The method has satisfactory accuracy, sensitivity and reproducibility. In contrast to methods commonly used to monitor heparin therapy, it measures heparin directly and is uninfluenced by patient variables such as low antithrombin III. The method may provide valuable information in selected clinical settings such as cardiopulmonary bypass and in patients with chronic renal disease who receive heparin during hemodialysis or prior to surgery.

Accession: 005395141

PMID: 7064128

DOI: 10.1016/0049-3848(82)90220-1

Download PDF Full Text: Evaluation of a heparin assay method using a fluorogenic synthetic peptide substrate for thrombin



Related references

Assay method of plasma plasminogen by means of a synthetic fluorogenic peptide substrate (3104-V). Rinsho Byori. Japanese Journal of Clinical Pathology 28(8): 804-807, 1980

Assay for plasma heparin using a synthetic peptide substrate for thrombin introduction of the fluorophore amino iso phthalic acid di methyl ester. Thrombosis Research 13(1): 47-52, 1978

The use of the fluorogenic synthetic substrate assay for the clinical determination of heparin. Thrombosis & Haemostasis: 308, 1979

Evaluation of a thrombin-sensitive fluorogenic substrate for heparin concentration in plasma. Thrombosis Research 25(3): 237-243, 1982

Assay method for urinary urokinase using synthetic fluorogenic substrate. Rinsho Byori. Japanese Journal of Clinical Pathology 27(3): 218-222, 1979

Clinical studies of the use of a fluorogenic substrate assay for the determination of anti thrombin iii activity. Thrombosis & Haemostasis 42(2): 20, 1979

Method for converting a peptide substrate of a proteinase to a fluorogenic substrate. Journal of Cellular Biochemistry Supplement 0(18D): 133, 1994

Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay. Methods in Molecular Biology 1406: 161-170, 2016

Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin. Nature Biotechnology 18(2): 187-193, 2000

Prenatal diagnosis of Sanfilippo A syndrome: experience in 35 pregnancies at risk and the use of a new fluorogenic substrate for the heparin sulphamidase assay. Prenatal Diagnosis 16(9): 829-835, 1996